Nonadherence according to clinical, bacteriological and radiological features, type of tuberculosis, and treatment characteristics in 70 tuberculosis human immunodeficiency virus-infected patients
| Adherence | Nonadherence | OR | p‐value | |
| Sex (male) | 44 (93.6%) | 18 (78.3%) | 0.3 | 0.104 |
| Age# yrs | 32.4±6.3 | 30.6±6.3 | 0.270 | |
| Drug addiction | 39 (83.0%) | 21 (91.3%) | 2.1 | 0.480 |
| Presence of other illness | 30 (63.8%) | 16 (69.6%) | 1.3 | 0.836 |
| Use of nucleoside analogous | 30 (63.8%) | 6 (26.1%) | 0.2 | 0.007 |
| Use of protease inhibitors | 5 (10.6%) | 2 (8.7%) | 0.8 | 0.995 |
| Current i.v. drug use¶ | 4 (10.3%) | 14 (66.7%) | 17.5 | <0.001 |
| Methadone+ | ||||
| In CDP | 7 (19.4%) | 0 (0.0%) | 0.00 | 0.082 |
| Other clinics | 3 (9.4%) | 2 (9.5%) | 1.0 | 0.995 |
| Multidrug resistance§ | 3 (8.3%) | 4 (20.0%) | 2.7 | 0.234 |
| Previous tuberculosis therapy | 2 (4.3%) | 2 (8.7%) | 2.1 | 0.593 |
| Modified treatment | 6 (12.8%) | 7 (30.4%) | 3.0 | 0.103 |
| Complications | 5 (10.6%) | 13 (56.5%) | 10.9 | <0.001 |
Data are presented as n (%), unless otherwise stated
OR: odds ratio
i.v.: intravenous
CPD: centre for ambulatory treatment of respiratory diseases
#: mean±sd
¶: data for the 60 patients in whom the risk was drug addiction
+: in comparison with no use of methadone
§: includes only the 56 patients in which a sensibility test to drugs had been carried out